Literature DB >> 20608894

Long-term compliance of salt restriction and blood pressure control status in hypertensive outpatients.

Yuko Ohta1, Takuya Tsuchihashi, Uran Onaka, Eri Miyata.   

Abstract

The purpose of the present study was to investigate the long-term compliance with salt restriction and blood pressure (BP) control status in Japanese hypertensive outpatients. Subjects included 103 patients, 59 women and 44 men, mean age 67 +/- 9 years, who underwent successful 24-h home urine collection more than 10 times over an interval of 5 years. Urinary salt, potassium, and creatinine were measured. During the follow-up period (average 8.6 years), participants underwent urine collection 11.4 times in average. Urinary salt excretion at the last visit was significantly lower than that of the first visit (8.2 +/- 3.1 vs. 9.6 +/- 3.7 g/day; p < 0.01). The achievement of urinary salt excretion <6 g/day increased from 18.5% at the first visit to 26.2% at the last visit. Similarly, BP at the last visit was significantly lower than that of the first visit (130 +/- 14/69 +/- 11 vs. 145 +/- 17/86 +/- 12 mmHg; p < 0.01). The achievement rate of BP <140/90 mmHg and <130/85 mmHg also increased significantly during this period (39.2% to 70.8% and 13.7% to 39.6%, respectively, p < 0.01). Results suggest that urinary salt excretion decreased by repeated measurements using 24-h home urine collection. Lifestyle modification including weight loss as well as the intensive antihypertensive treatment contributed to the improved BP control during this period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608894     DOI: 10.3109/10641963.2010.491888

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  8 in total

1.  Self-management of salt intake: clinical significance of urinary salt excretion estimated using a self-monitoring device.

Authors:  Kenichiro Yasutake; Noriko Horita; Yoko Umeki; Yukiko Misumi; Yusuke Murata; Tomomi Kajiyama; Itsuro Ogimoto; Takuya Tsuchihashi; Munechika Enjoji
Journal:  Hypertens Res       Date:  2015-11-12       Impact factor: 3.872

2.  Estimated urinary salt excretion by a self-monitoring device is applicable to education of salt restriction.

Authors:  Kenichiro Yasutake; Noriko Horita; Yusuke Murata; Susumu Koyama; Munechika Enjoji; Takuya Tsuchihashi
Journal:  Hypertens Res       Date:  2014-10-23       Impact factor: 3.872

3.  Relationship between salt intake as estimated by a brief self-administered diet-history questionnaire (BDHQ) and 24-h urinary salt excretion in hypertensive patients.

Authors:  Satoko Sakata; Takuya Tsuchihashi; Hideyuki Oniki; Mitsuhiro Tominaga; Kimika Arakawa; Minako Sakaki; Takanari Kitazono
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 4.  Dietary salt intake in Japan - past, present, and future.

Authors:  Takuya Tsuchihashi
Journal:  Hypertens Res       Date:  2022-03-16       Impact factor: 3.872

5.  Characteristics of sodium sensitivity in Korean populations.

Authors:  Sung Joon Shin; Chi Yeon Lim; Moo-Yong Rhee; Sang Woo Oh; Sang Hoon Na; Yongsoon Park; Cho-Il Kim; Seo-Young Kim; Jong-Wook Kim; Hye-Kyung Park
Journal:  J Korean Med Sci       Date:  2011-07-27       Impact factor: 2.153

Review 6.  The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Authors:  Hakuo Takahashi; Masamichi Yoshika; Yutaka Komiyama; Masato Nishimura
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

7.  Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.

Authors:  Chia-Hsien Chang; Makiko Kusama; Shunsuke Ono; Yuichi Sugiyama; Takao Orii; Manabu Akazawa
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

8.  Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.

Authors:  Chia-Hsien Chang; Motonobu Sakaguchi; Paul Dolin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-05-25       Impact factor: 2.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.